A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
Active, not recruiting · NCT06564194 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV | Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, infectious disease | Active, not recruiting | Phase 1 | 2026-04-23 | NCT06564194 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Immorna Biotherapeutics, Inc. | 3 |
| Tigermed Consulting Co., Ltd | 6 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| DelRicht - New Orleans | New Orleans | United States | 2 |
| Health Awareness | Jupiter | United States | 3 |
| Sundance Clinical Research | St Louis | United States | 1 |